Results 181 to 190 of about 561,728 (244)

Author Correction: Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy. [PDF]

open access: yesNat Metab
Wang H   +13 more
europepmc   +1 more source

Daridorexant‐ Case Report of Possible Side‐Effect in Rare Mitochondrial Disorder

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT This case report describes a 40‐year‐old woman with maternally inherited diabetes and deafness (MIDD), a rare mitochondrial disorder, who received treatment with daridorexant due to severe chronic insomnia. She developed progression of her MIDD symptoms during treatment.
Sven Svedmyr, Joel Bergqvist
wiley   +1 more source

Selenium Levels in Brazil Nuts: A Global Review of the Literature

open access: yesNutrition Bulletin, EarlyView.
ABSTRACT Brazil nuts (BN, Bertholletia excelsa, Lecythidaceae) are frequently recommended for increasing selenium intake. Many individuals residing in regions with low soil selenium values, particularly including vegetarians, have selenium intakes below the dietary reference values. A literature review of selenium levels in BN was conducted to estimate
Christian Koeder   +2 more
wiley   +1 more source

Cardiovascular Outcomes of GLP‐1–Based Medicines Among People With Overweight and Obesity: An Umbrella Review of Meta‐Analyses of Randomized Controlled Trials

open access: yesObesity Reviews, EarlyView.
ABSTRACT Introduction Cardiovascular (CV) outcomes of Glucagon‐like peptide‐1 (GLP‐1)–based medicines among people with overweight and obese (OW/OB) population have been investigated by meta‐analyses of randomized controlled trials (RCTs), but an overall summary is lacking.
Muhammed Rashid   +6 more
wiley   +1 more source

Racial outcomes in patients with diabetic cardiomyopathy treated with an aldose reductase inhibitor: the ARISE-HF trial. [PDF]

open access: yesOpen Heart
Batista JL   +13 more
europepmc   +1 more source

Targeting Overweight and Obesity Phenotypes for Secondary Prevention of Cardiovascular Disease: A Call to Action for the Middle East and Beyond

open access: yesObesity Reviews, EarlyView.
ABSTRACT Although there are conflicting clinical data on the efficacy of weight reduction in reducing secondary events in patients with comorbid overweight and obesity (OAO) and cardiovascular disease (CVD), there is excellent epidemiological and biological evidence of a cause–effect relationship between OAO, CVD, and other systemic complications ...
Wael Almahmeed   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy